Clinical Trials Browser

Phase 1/2 × Lymphoma × Genes × Clear all

NCT00858793 2022-09-08

High-dose Chemotherapy With Transplantation of Gene-modified Haematopoietic Stem Cells for HIV-positive Patients With Malignant Diseases Indicating an HSCT

Phase 1/2 Terminated

Acquired Immunodeficiency Syndrome, Lymphoma, HIV Infections, Lymphoma, AIDS-Related